A Safety Study of Oraxol (HM30181 + Oral Paclitaxel) in Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Solid Tumor
Related studies linked through entity extraction aliases.
The Basket Study of Pyrotinib Maleate for HER2-Postive Solid Tumor
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase I /IIa Study of RC88-ADC in Subjects With Advanced Malignant Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Poziotinib in Patients With Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Activating Mutations in Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Evaluate the Efficacy and Safety of Anti-PD-1 Antibody AK105 in Patients With Selected Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes
- Status
- TERMINATED
- Phase
- PHASE2
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Azenosertib (ZN-c3) in Participants With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Clinical Trial of BAT1306 and BAT8001 Injection in Patients With Solid Tumor
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Phase 1 Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of ATOR-1017
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of AP-002 in Patients With Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Study to Assess Safety and Efficacy of the Second Mitochondrial-derived Activator of Caspases (SMAC) Mimetic Debio 1143
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
MAX-10181 Given Orally to Patients With Advanced Solid Tumor
- Status
- UNKNOWN
- Phase
- PHASE1
Study of ADG116 in Patients With Advanced/Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Precision Medicine for Patients With Identified Actionable Mutations
- Status
- TERMINATED
- Phase
- PHASE2
Prospective Analysis of Intestinal Microbiome and Autoimmune Panels as Predictors of Toxicity in ImmunOncology Patients
- Status
- RECRUITING
- Phase
- N/A
Trial Comparing Parenteral Nutrition (PN) Using Eurotubes® vs. 2/3-chamber Bags in Subjects With Solid Tumors Requiring PN (PEKANNUSS)
- Status
- TERMINATED
- Phase
- N/A
Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of LY3435151 in Participants With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Safety and Efficacy of SB 11285 Alone and in Combination With Atezolizumab in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1